Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126008491 | 12600849 | 1 | I | 20160617 | 20160617 | 20160727 | 20160727 | PER | US-ASTRAZENECA-2016SE67566 | ASTRAZENECA | 12448.00 | DY | F | Y | 71.20000 | KG | 20160728 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126008491 | 12600849 | 1 | PS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 3.6 | MG | IMPLANT | ||||||||
| 126008491 | 12600849 | 2 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 3.6 | MG | IMPLANT | ||||||||
| 126008491 | 12600849 | 3 | SS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 19726 | 3.6 | MG | IMPLANT | ||||||||
| 126008491 | 12600849 | 4 | C | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 0 | 318 | MG | |||||||||
| 126008491 | 12600849 | 5 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 50 | MG | |||||||||
| 126008491 | 12600849 | 6 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0 | 25 | MG | |||||||||
| 126008491 | 12600849 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 0 | |||||||||||
| 126008491 | 12600849 | 8 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126008491 | 12600849 | 1 | Breast cancer female |
| 126008491 | 12600849 | 2 | Breast cancer female |
| 126008491 | 12600849 | 3 | Breast cancer female |
| 126008491 | 12600849 | 4 | Breast cancer female |
| 126008491 | 12600849 | 5 | Chemotherapy |
| 126008491 | 12600849 | 6 | Chemotherapy |
| 126008491 | 12600849 | 7 | Chemotherapy |
| 126008491 | 12600849 | 8 | Chemotherapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126008491 | 12600849 | Circumstance or information capable of leading to medication error | |
| 126008491 | 12600849 | Device defective | |
| 126008491 | 12600849 | Device deployment issue | |
| 126008491 | 12600849 | Injection site haemorrhage | |
| 126008491 | 12600849 | Off label use | |
| 126008491 | 12600849 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126008491 | 12600849 | 1 | 20160505 | 0 | ||
| 126008491 | 12600849 | 2 | 20160528 | 0 | ||
| 126008491 | 12600849 | 3 | 20160617 | 0 | ||
| 126008491 | 12600849 | 4 | 20160519 | 0 | ||
| 126008491 | 12600849 | 5 | 20160519 | 0 | ||
| 126008491 | 12600849 | 6 | 20160519 | 0 | ||
| 126008491 | 12600849 | 7 | 20160519 | 0 | ||
| 126008491 | 12600849 | 8 | 20160519 | 0 |